<?xml version="1.0" encoding="UTF-8"?>
<p id="Par3000">The use of L-carnitine in the treatment of VPA poisoning accelerates the elimination of VPA and facilitates the decrease in ammoniac plasma levels, therefore reducing systemic toxicity and encephalopathy risk. Further controlled, extented trials are required to better elucidate the therapeutic and prophylactic roles of L-carnitine in the management of VPA toxicity.</p>
